The Newborn Screening session will be discussing reporting, interpretation, follow-up, interstate variability, new additions (the RUSP, process, and interstate variability).
This educational activity is supported by an educational grant from Ultragenyx.
Thank you for attending the Newborn Screening session on August 19, 2022! Below are links to access this session's slide deck and recorded course materials.
Shawn McCandless, MD
Children's Hospital Colorado
Shawn McCandless, MD, speaker for this session, is a speaker for Horizon Therapeutics, a researcher for Aardvark Therapeutics, Levo Therapeutics, Ultragenyx and Harmony Therapeutics and a consultant for Levo Therapeutics.
Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies.
All of the relevant financial relationships listed have been mitigated.
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this Other (Internet Live) activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
A general certificate of attendance will be available after the completion of the online evaluation. Claim only credit commensurate of your conference attendance.
- 1.50 AMA PRA Category 1 Credit™
- 1.50 Attendance